Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
603193.SS
HOLDREMOVEGet insider-trade alertsRunben Biotechnology Co., Ltd. · Consumer Defensive · China · $1.1B · Avg Vol: $8M/d
Runben Biotechnology is a high-quality consumer defensive company in China with strong brand equity in niche categories. However, it lacks any connection to our active macro themes, failing the Druckenmiller lens for asymmetric macro tailwinds.
COMPANY DESCRIPTION
Runben Biotechnology Co., Ltd. develops and manufactures personal care and insect repellent products, focusing on mild, plant-based formulations for infants and sensitive skin. The company operates a highly successful omni-channel sales model, leveraging e-commerce platforms to achieve rapid brand growth in China. Its competitive moat is built on strong brand equity in the maternal and child care niche, agile product development, and cost-effective supply chain management.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | 126.1M | 152.1M | 194.1M | 227.5M | 21.7% |
| EPS | 0.07 | 0.09 | 0.11 | 0.11 | 18.4% |
| Shares | 343.9M | 404.6M | 404.6M | 404.6M | +17.6% |
| Debt | 1.2M | 0.6M | 0.4M | 0.2M | -43.6% |
| Equity | 106.4M | 283.0M | 306.4M | 327.1M | 45.4% |
| Op CF | 24.3M | 37.2M | 37.9M | 40.5M | 18.5% |
| Inv CF | 1.4M | -192.9M | -43.7M | -2.7M | — |
| Fin CF | -1.4M | 143.3M | -20.3M | -26.2M | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Consumer Defensive, ranked by industry match, size, and score similarity. Cross-listings of 603193.SS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 603193.SS | Runben Biotechnology Co., Ltd.(you) | $1.1B | 43 | HOLD |
| 003006.SZ | Chongqing Baiya Sanitary Products Co., Ltd. | $874M | 44 | HOLD |
| 300957.SZ | Yunnan Botanee Bio-Technology Group Co.LTD | $1.9B | 47 | HOLD |
| 6993.HK | Blue Moon Group Holdings Limited | $2.2B | 42 | HOLD |
| 605009.SS | Hangzhou Haoyue Personal Care Co., Ltd | $712M | 33 | SELL |
| 001328.SZ | Dencare (Chongqing) Oral Care Co., Ltd. | $636M | 33 | SELL |
| 600315.SS | Shanghai Jahwa United Co., Ltd. | $1.6B | 30 | SELL |
| 002919.SZ | Mingchen Health Co.,Ltd. | $740M | 25 | SELL |
| 6090.HK | Butong Group | $332M | 41 | HOLD |
| 002511.SZ | C&S Paper Co.,Ltd | $1.2B | 70 | BUY |
Peer medians: ROE 8.5% · P/E 19.5x · Gross margin 33.4%